Design and biological evaluation of 99mTc-N2S2-Tat(49–57)-c(RGDyK): A hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins

Authors

Keywords

Journal

Volume 40, Issue 4, Pages 481-487

Publisher

Elsevier BV

Online

2013-04-23

DOI

10.1016/j.nucmedbio.2013.01.003

Discuss science. Find collaborators. Network.

Join a conversation

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now